“Tumour Microenvironment Modulation to Overcome Checkpoint Resistance: Where the Preclinical Rationale Holds”. Translational Medicine & Therapeutics Journal 5, no. 2 (April 21, 2026): 28–36. Accessed November 5, 2026. https://inkwise.org/index.php/TMTJ/article/view/119.